Jaffetilchin Investment Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $224K | Sell |
2,705
-1,366
| -34% | -$113K | 0.01% | 391 |
|
|
2025
Q1 | $330K | Buy |
4,071
+1
| +0% | +$81 | 0.02% | 311 |
|
|
2024
Q4 | $367K | Sell |
4,070
-380
| -9% | -$34.2K | 0.03% | 276 |
|
|
2024
Q3 | $440K | Buy |
4,450
+166
| +4% | +$16.4K | 0.03% | 245 |
|
|
2024
Q2 | $397K | Buy |
4,284
+1,390
| +48% | +$129K | 0.03% | 246 |
|
|
2024
Q1 | $275K | Buy |
2,894
+354
| +14% | +$33.6K | 0.02% | 302 |
|
|
2023
Q4 | $227K | Buy |
+2,540
| New | +$227K | 0.02% | 313 |
|